Symtuza 800 mg (Darunavir (Darunavir Ethanolate)) Tablet

SYMTUZA 800 MG tablets contain darunavir (darunavir ethanolate), an antiretroviral medication used in HIV treatment. This oral tablet is manufactured by Janssen Inc. in Canada.

SYMTUZA 800 MG is primarily used as part of antiretroviral therapy to manage HIV infection. Darunavir, the active ingredient, works by inhibiting protease, an enzyme crucial for HIV replication. This medication is often combined with other antiretrovirals to create a comprehensive treatment regimen. What is SYMTUZA used for? It is typically prescribed to adults and children over 3 years old who are infected with HIV.

Common effects of SYMTUZA 800 MG may include nausea, diarrhea, headache, and rash. Some individuals might experience changes in body fat distribution or elevated liver enzymes. It's important to monitor for any unusual symptoms and consult a healthcare provider if they persist or worsen.

SYMTUZA should be handled with care, especially by those with liver problems or allergies to darunavir. It is crucial to follow the prescribed dosage and administration instructions. Regular medical check-ups are recommended to monitor the effectiveness and safety of the treatment.

SYMTUZA may interact with various medications, including other antiretrovirals, certain antibiotics, and drugs metabolized by the liver. It is important to inform healthcare providers about all current medications to avoid potential interactions. Alcohol and other substances that affect liver function should be used cautiously.